ロード中...
Prevention of cisplatin‐induced hearing loss in children: Informing the design of future clinical trials
Cisplatin is an essential chemotherapeutic agent in the treatment of many pediatric cancers. Unfortunately, cisplatin‐induced hearing loss (CIHL) is a common, clinically significant side effect with life‐long ramifications, particularly for young children. ACCL05C1 and ACCL0431 are two recently comp...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6051159/ https://ncbi.nlm.nih.gov/pubmed/29846043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1563 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|